NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma
- Eudocia Q. Lee
- , Peixin Zhang
- , Patrick Y. Wen
- , Elizabeth R. Gerstner
- , David A. Reardon
- , Kenneth D. Aldape
- , John F. deGroot
- , Edward Pan
- , Jeffrey J. Raizer
- , Lyndon J. Kim
- , Steven J. Chmura
- , H. Ian Robins
- , Jennifer M. Connelly
- , James D. Battiste
- , John L. Villano
- , Naveed Wagle
- , Ryan T. Merrell
- , Merideth M. Wendland
- , Minesh P. Mehta
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations